Substituted heteroaryl- and phenylsulfamoyl compounds

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S070500, C514S071000

Reexamination Certificate

active

11012139

ABSTRACT:
The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use of such compounds as peroxisome proliferator activator receptor (PPAR) agonists. PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans. The compounds are also useful for the treatment of negative energy balance (NEB) and associated diseases in ruminants.

REFERENCES:
patent: 3658990 (1972-04-01), Werner
patent: 3806542 (1974-04-01), Werner
patent: 3812104 (1974-05-01), Werner
patent: 3843662 (1974-10-01), Holland
patent: 3879402 (1975-04-01), Holland
patent: 3929803 (1975-12-01), Holland
patent: 4495439 (1985-01-01), Shimoma et al.
patent: 5413892 (1995-05-01), Matsuura et al.
patent: 6063173 (2000-05-01), Torii et al.
patent: 6200995 (2001-03-01), De la Brouse-Elwood et al.
patent: 6316450 (2001-11-01), Bromidge et al.
patent: 6528528 (2003-03-01), Connor et al.
patent: 6583157 (2003-06-01), McGee et al.
patent: 6620827 (2003-09-01), De la Brouse-Elwood et al.
patent: 6653332 (2003-11-01), Jaen et al.
patent: 2003/0187001 (2003-10-01), Calderwood et al.
patent: 2004/0102500 (2004-05-01), Cano et al.
patent: 2004/0235212 (2004-11-01), Ishizaki
patent: 2004/0254160 (2004-12-01), Starke et al.
patent: 2005/0014833 (2005-01-01), Clark et al.
patent: 2005/0020684 (2005-01-01), Brooks et al.
patent: 2005/0288340 (2005-12-01), Hamanaka
patent: 558789 (1975-02-01), None
patent: 0068407 (1983-01-01), None
patent: 0068408 (1983-01-01), None
patent: 2090136 (1982-07-01), None
patent: 0378179 (2003-02-01), None
patent: 0216543 (1990-01-01), None
patent: 200189412 (2001-04-01), None
patent: WO9938845 (1999-08-01), None
patent: WO 0174786 (2001-10-01), None
patent: WO 0182916 (2001-11-01), None
patent: WO 0238553 (2002-05-01), None
patent: WO 02100813 (2002-12-01), None
patent: WO 03016265 (2003-02-01), None
patent: WO 03020710 (2003-03-01), None
patent: WO 03043997 (2003-05-01), None
patent: WO 03087044 (2003-10-01), None
patent: WO0182916 (2006-08-01), None
*English language equivalent to JP 02-16543.
Spain, J. N., et al.,Tri-State Dairy Nutrition Conference, pp. 13-34, (2001).
Douglas, G. N., et al., Lipid metabolism and production by Holstein cows fed control or high fat diets at restricted or ad libitum Intakes during the dry period,J. Dairy Science, vol. 81, Suppl. 1, p. 295, (1998).
English language translation of JP 2001-89412.
* Equivalent to WO 99/38845.
**Equivalent to WO 01/842916.
*Equivalent to WO 02/38553.
**Equivalent to WO 03/043997.
***Equivalent to WO 03/020710.
****Equivalent to WO 03/016265.
*****Equivalent to WO 02/100813.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted heteroaryl- and phenylsulfamoyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted heteroaryl- and phenylsulfamoyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heteroaryl- and phenylsulfamoyl compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3837205

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.